Company Filing History:
Years Active: 2022-2024
Title: Celebrating the Innovations of Inventor Randall Wagner
Introduction: Randall Wagner is a notable inventor based in Bend, OR, whose contributions to the field of medicine are underscored by his innovative spirit and dedication to improving healthcare. With a focus on calcium channel modulators, his inventions have the potential to address significant medical conditions such as epilepsy and psychiatric disorders.
Latest Patents: Randall Wagner holds two patents, both centered around formulations of T-type calcium channel modulators. These patents describe various dosage forms and compositions that are designed to prevent and treat diseases related to the dysfunction of T-type calcium channels. Specifically, the inventions target conditions such as epilepsy, including absence seizures and juvenile myoclonic epilepsy, as well as essential tremor and mood disorders like major depressive disorder. Additionally, the patent presents methods for effectively modulating the function of T-type calcium channels.
Career Highlights: Randall Wagner is associated with Praxis Precision Medicines, Inc., a company that is dedicated to developing novel therapies for neurologic and psychiatric disorders. His work there aims to make strides in the understanding and treatment of challenging health issues faced by many patients.
Collaborations: Throughout his career, Randall has collaborated with esteemed colleagues, including Kiran Reddy and Margaret S. Lee. These partnerships have enabled the exchange of ideas and contributed to the advancement of his innovative work in the field of medicine.
Conclusion: Randall Wagner exemplifies the attributes of a visionary inventor, dedicated to harnessing innovation to solve pressing medical challenges. His patents not only reflect his expertise but also his commitment to improving the quality of life for individuals affected by debilitating conditions. The ongoing research and development within Praxis Precision Medicines, Inc. positions them as leaders in the pursuit of therapeutic breakthroughs.